Ahmadyar, Gina
Carlson, Josh J.
Kimura, Alan
Alobaidi, Ali
Hallak, Joelle
Hansen, Ryan N.
Funding for this research was provided by:
AbbVie
Article History
Received: 14 February 2023
Accepted: 22 August 2023
First Online: 18 September 2023
Declarations
:
: All analyses conducted in this study are in accordance with the relevant guidelines and regulations. Ethical approval and informed consent were waived by the Institutional Review Board (IRB) at the University of Washington.
: not applicable.
: A.A. and J.H. are employees of AbbVie and may hold AbbVie stock. J.C. is a consultant for AbbVie. A.K. is a consultant for Biogen and RetinAI and holds stock in Abbott Laboratories. G.A. and R.H. have no relevant disclosures.